| CPC C07K 7/64 (2013.01) [A61K 47/64 (2017.08); A61K 49/0056 (2013.01); A61K 51/088 (2013.01); A61P 35/00 (2018.01); C07K 1/1077 (2013.01)] | 18 Claims |
|
1. A CAIX-specific peptide construct comprising a peptide ligand consisting of any one of amino acid sequence selected from the group consisting of SEQ ID NOs: 1 to 44, wherein at least one of the constituent amino acids is composed of D-amino acids and a lysine (Lys) residue among the constituent amino acids may be substituted with a chemical functional group at the side chain ε-amino group; and
a sulfonamide functional group-containing amino acid residue linked to the peptide ligand directly or through a spacer;
wherein the peptide construct has a cyclic structure represented by Formula 1 below:
![]() wherein,
P is the peptide ligand,
F1 is a glycine (Gly) or a sulfonamide functional group-containing amino acid residue,
F2 is a sulfonamide functional group-containing amino acid residue,
F3 is a glycine (Gly) or a functional group-containing amino acid residue other than sulfonamide,
n and m are each independently 0 or 1,
F4 is a group of the general formula —(S1)o—(F5)p—(S2)q—(F6)r—NH2, wherein
S1 and S2 are each independently a spacer,
F5 and F6 are each independently a functional group-containing amino acid residue other than sulfonamide,
wherein the functional group other than sulfonamide is chelator, cycloalkane having 5 to 15 carbon atoms, biotin, glucoheptonic acid, 4-(p-iodophenyl) butyric acid (IB), fluorescent dye, or cytotoxic agent, and
o, p, q and r each independently represent an integer of 0 to 6.
|